To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
Microtubule-Associated Protein Tau Plasmids
DNA Plasmids
DNA Plasmids encoding various MAPT cDNA inserts
VPS35 Plasmids
DNA Plasmids
DNA Plasmids encoding various VPS35 cDNA inserts
PINK1 Plasmids
DNA Plasmids
DNA Plasmids encoding various PINK1 cDNA inserts
Parkin Plasmids
DNA Plasmids
DNA Plasmids encoding various Parkin cDNA inserts
LRRK2 pT1503 Phosphospecific Antibody
Antibody
Rabbit monoclonal phosphospecific antibody directed against Threonine1503 of LRRK2.
LRRK2 Full-Length Protein (Human)
Protein
Full-Length human LRRK2 protein generated in vitro and assessed for kinase activity.
TH-GFP Rat (non-X-linked)
Rat Model
Rats expressing green fluorescent protein (GFP) under the rat tyrosine hydroxylase (TH) promotor. This is a non-X-linked mutation.
Lentiviral eGFP-LRRK2 (wild-type)
Viral Vector
Lentiviral vector encoding wild-type LRRK2 and eGFP. Lentiviral eGFP available as a control in Reporter section.
Please note: This viral vector is not intended for in vivo use.
LRRK2 Antibody (MJFF2)
Antibody
Rabbit monoclonal antibody directed against wild-type LRRK2. The antibody was mapped to the LRR domain of LRRK2 (AA 1035-1239).
Lentiviral eGFP
Viral Vector
Lentiviral vector encoding eGFP
Please note: This viral vector is not intended for in vivo use.
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic